Fecal transplants could be used in conjunction with current cancer treatments to boost results. /Getty Images THIERRY ZOCCOLAN/Getty Images Combining fecal transplants with immune checkpoint inhibitors such as pembrolizumab or nivolumab showed the procedure was safe in people with advanced melanoma, according to a phase 1 clinical trial. Of the study participants, 65% responded positively to...
By Paul McClure July 09, 2023 Following a phase 1 safety trial, researchers have found that combining immunotherapy for melanoma with fecal transplantation is safe and may improve treatment success Depositphotos A phase 1 clinical trial exploring the use of fecal transplants to supplement immunotherapy treatment for melanoma has found it to be safe and has the...
LAWSON HEALTH RESEARCH INSTITUTE IMAGE: DR. SAMAN MALEKI AND DR. JOHN LENEHAN DISCUSS THE RESULTS OF THEIR RECENT STUDY ON FECAL TRANSPLANTS FOR ADVANCED MELANOMA PATIENTS. CREDIT: LAWSON HEALTH RESEARCH INSTITUTE LONDON, ON – In a world-first clinical trial published in the journal Nature Medicine, a multi-centre study from Lawson Health Research Institute, the Centre hospitalier de l’Université de Montréal (CHUM) and the...
Penn study shows GPER activation in mice can also make tumors more visible to immune system. Activating the G protein-coupled estrogen receptor (GPER) – a receptor found on the surface of many normal and cancer tissues – has been shown to stop pancreatic cancer from growing, but may also make tumors more visible to the...
Sunscreen is an essential commodity to protect the skin from harmful effects of ultraviolet (UV) rays. It is also used widely to prevent skin cancer. However, it is important to apply sunscreen appropriately to get its full benefits. Is sunlight always good? Although sunlight is vital for many physiological functions, such as vitamin D synthesis...
CANCER RESEARCH UK The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications today.* Researchers from the Babraham Institute, AstraZeneca and the Cancer Research UK Cambridge Centre have demonstrated...
by Newcastle University ITV Tyne Tees presenter, Pam Royle, is one of the first to try a new test developed by Newcastle University which predicts whether her skin cancer is likely to return. The test which reliably predicts that a melanoma is unlikely to spread or return has been developed by scientists at Newcastle University....
The risk of developing melanoma is significantly multiplied for people who have red hair and more than 20 large moles, University of Queensland researchers have found. People with these physical traits have a one in four chance of developing the disease in their lifetime. The study also showed that people without red hair, but who...
This is Dr Jeffrey Weber. I am a medical oncologist at the Laura and Isaac Perlmutter Cancer Center at New York University Langone Health in New York City. Today we will be talking about a very interesting article that appeared several months ago in the Journal of Clinical Oncology,[1] which I think sheds light on...
In UCLA-led study, new treatment is more effective in people receiving immunotherapy for the first time UNIVERSITY OF CALIFORNIA – LOS ANGELES HEALTH SCIENCES A UCLA-led study has found that a treatment that uses a bacteria-like agent in combination with an immunotherapy drug could help some people with advanced melanoma, an aggressive form of skin...
